MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹5,664 Cr | ₹2,120 Cr | ₹1,863 Cr | ₹2,623 Cr | ₹1,353 Cr |
What is the latest Total Current Liabilities ratio of MANKIND PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹5,664 Cr |
Mar2024 | ₹2,120 Cr |
Mar2023 | ₹1,863 Cr |
Mar2022 | ₹2,623 Cr |
Mar2021 | ₹1,353 Cr |
How is Total Current Liabilities of MANKIND PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹5,664 Cr | 167.18 | |
Mar2024 | ₹2,120 Cr | 13.77 | |
Mar2023 | ₹1,863 Cr | -28.98 | |
Mar2022 | ₹2,623 Cr | 93.84 | |
Mar2021 | ₹1,353 Cr | - |
Compare Total Current Liabilities of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹107,171.1 Cr | 3% | 6.2% | 7.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,451.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,727.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
CIPLA | ₹124,533.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹123,673.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,629.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 3% |
6.2% |
7.5% |
SENSEX | 0.5% |
0.4% |
-1.1% |
You may also like the below Video Courses